You're reading the free version. Trader adds the live tape and alerts.
Start tracking
NRIX Sale Disclosure
Hansen Gwenn · SEC Form 4 · Filed Jun 25, 2026
Sale
Calculated transaction value
$107.88K
Hansen Gwenn Chief Scientific Officer
NRIX
Nurix Therapeutics
NRIX
Transaction date
Jun 25, 2026
Public filing date
Jun 25, 2026
Filing lag
Filed same day
NRIX daily price context
Close on/before transaction
$22.46
Jun 25, 2026
First close after public filing
$22.9
Jun 26, 2026
30-day return after filing
+2.31%
Through Jul 27, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 5,394 shares @ $20
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001817160-26-000010
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$107.88K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Nurix Therapeutics, Inc. NRIX Current | Sale | Jun 25, 2026 | $107.88K |